EMA grants orphan drug designation to PIQUR’s lead compound PQR309 to treat patients with DLBCL
What is orphan drug designation? The EMA orphan drug designation is a status assigned to a medicine intended for use against a... Read More
ARMO BioSciences’ Immunotherapy AM0010 Receives Orphan Designation in Europe
Posted on24 Dec 2016
TagsEuropean Medicine Agency, Orphan Designation in Europe, orphan drug, orphan drug act, orphan drug designation
Comments0
ARMO BioSciences, Inc., a clinical-stage immuno-oncology company, announced that the European Commission (EC) has granted the Company’s lead investigational immuno-oncology drug AM0010... Read More
USFDA approved new drug Rubraca, rucaparib
The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian... Read More
Zymeworks’ ZW25, ZW33 received Orphan Drug designation for ovarian cancer
Zymeworks Inc., a biopharmaceutical company discovering and developing innovative multi-functional protein-based therapeutics, including bi-specific antibodies and drug conjugates for the treatment of... Read More
Allena’s oxalate decarboxylase to treat paediatric hyperoxaluria gets US FDA orphan drug status
Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercialising innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan... Read More
Orphan Drug & Orphan Drug Act
The Orphan Drug Act (ODA) provides for granting special status to a product to treat a rare disease or condition upon request... Read More